Waqar M. Haque, MD

Assistant Professor of Clinical Radiation Oncology, Institute for Academic Medicine
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Haque is a native Houstonian and attended medical school at Baylor College of Medicine. He graduated in 2010 as a member of the Alpha Omega Alpha Medical Honor Society.  He completed residency in radiation oncology at the University of Texas Medical Branch in Galveston, during which he also spent time training at the MD Anderson Cancer Center.


Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States
Verma, V, Brian Butler, E, Teh, BS & Haque, WM 2019, Anticancer Research, vol. 39, no. 6, pp. 3137-3140. https://doi.org/10.21873/anticanres.13450

Pathologic nodal clearance and complete response following neoadjuvant chemoradiation for clinical N2 non-small cell lung cancer: Predictors and long-term outcomes
Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Lung Cancer, vol. 130, pp. 93-100. https://doi.org/10.1016/j.lungcan.2019.02.003

Postmastectomy radiation therapy for triple negative, node-negative breast cancer
Haque, WM, Verma, V, Farach, AM, Butler, EB & Teh, BS 2019, Radiotherapy and Oncology, vol. 132, pp. 48-54. https://doi.org/10.1016/j.radonc.2018.11.012

Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma
Haque, WM, Arms, A, Verma, V, Hatch, S, Brian Butler, E & Teh, BS 2019, Breast, vol. 43, pp. 67-73. https://doi.org/10.1016/j.breast.2018.11.007

Reply to the letter “Pure or mixed type invasive lobular carcinoma; are they different from each other?”
Haque, WM & Teh, BS 2019, Breast, vol. 43, pp. 151-152. https://doi.org/10.1016/j.breast.2018.12.006

Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer
Haque, WM, Verma, V, Butler, EB, Teh, BS & Rusthoven, CG 2019, Lung Cancer, vol. 127, pp. 76-83. https://doi.org/10.1016/j.lungcan.2018.11.026

Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes
Jiang, W, Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Acta Oncologica. https://doi.org/10.1080/0284186X.2018.1562207

Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States
Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Journal of Immunotherapy. https://doi.org/10.1097/CJI.0000000000000264

Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma
Jiang, W, Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Acta Oncologica. https://doi.org/10.1080/0284186X.2019.1631472

Cancer related fatigue in prostate cancer
Randall, J, Haque, WM, Butler, EB & Teh, BS 2019, Translational Andrology and Urology, vol. 8, pp. S106-S108. https://doi.org/10.21037/tau.2018.12.06

Omission of radiation therapy following breast conservation in older (=70 years) women with T1-2N0 triple-negative breast cancer
Haque, WM, Verma, V, Hsiao, KY, Hatch, S, Arentz, C, Szeja, S, Schwartz, M, Niravath, PA, Bonefas, E, Miltenburg, D, Butler, EB & Teh, BS 2019, Breast Journal. https://doi.org/10.1111/tbj.13443

Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival
Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Diseases of the Esophagus, vol. 32, no. 4. https://doi.org/10.1093/dote/doy067

Survival Outcomes and Patterns of Management for Anal Adenocarcinoma
Lewis, GD, Haque, WM, Butler, EB & Teh, BS 2019, Annals of Surgical Oncology. https://doi.org/10.1245/s10434-019-07202-4

The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast
Lewis, GD, Xing, Y, Haque, WM, Patel, T, Schwartz, MR, Chen, AC, Farach, AM, Hatch, SS, Butler, EB, Chang, JC & Teh, BS 2019, Breast Journal. https://doi.org/10.1111/tbj.13432

Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
Haque, WM, Verma, V, Aghazadeh, M, Darcourt, J, Butler, EB & Teh, BS 2019, Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2019.06.015

Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma
Ryckman, JM, Surkar, SM, Haque, WM, Butler, EB, Teh, BS & Verma, V 2019, American Journal of Clinical Oncology: Cancer Clinical Trials. https://doi.org/10.1097/COC.0000000000000511

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Verma, V, Sprave, T, Haque, WM, Simone, CB, Chang, JY, Welsh, JW & Thomas, CR 2018, Journal for ImmunoTherapy of Cancer, vol. 6, no. 1, 128, pp. 128. https://doi.org/10.1186/s40425-018-0442-7

Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes
Haque, WM, Verma, V, Hatch, S, Klimberg, VS, Butler, EB & Teh, BS 2018, Breast, vol. 41, pp. 67-73. https://doi.org/10.1016/j.breast.2018.06.014

Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion
Cushman, TR, Haque, WM, Menon, H, Rusthoven, CG, Butler, EB, Teh, BS & Verma, V 2018, Journal of gynecologic oncology, vol. 29, no. 6, e97, pp. e97. https://doi.org/10.3802/jgo.2018.29.e97

Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States
Haque, WM, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol. 9, no. 4, pp. 601-609. https://doi.org/10.21037/jgo.2018.05.08

Live Chat Available